Martin Fan is a Vice President, Equity Research with over a decade of experience in drug discovery and analytics within the biotechnology sector. Before joining equity research, he held scientific and business development roles across both industry and academic institutions, with therapeutic focuses in oncology, vaccines and infectious diseases, and autoimmunity. His experience spans the bench to the boardroom—having worked as a bench scientist and later in business development—giving him a unique perspective on the biotech landscape. Prior to transitioning into research, Martin also worked in business consulting, where he specialized in translating complex clinical and scientific data for both specialist and generalist investors. Martin earned his B.S. in Biochemistry from Washington University in St. Louis and holds a Ph.D. in Immunology from Harvard University.
Martin brings deep sector expertise in autoimmunity, allergies, and inflammation. His combined scientific and commercial background enables him to identify underappreciated risks and opportunities in early- and late-stage biotech companies. Having worked directly in biotech and consulted on strategy, Martin has a nuanced understanding of how science translates into pipeline value and a unique ability to communicate complex scientific insights in a way that resonates with diverse investor audiences.
Since our founding in 1955, Wedbush has been a leader in the financial services industry providing our clients, both private and institutional, with a wide range of securities brokerage, wealth management, and investment banking services; Headquartered in Los Angeles, California with 100 registered offices and nearly 900 colleagues, the firm focuses on client service and financial safety, innovation, and the utilization of advanced technology.
Follow us on LinkedIn, Twitter, and Facebook.
The background of this firm and investment professionals may be found on FINRA’s BrokerCheck
Wedbush Financial Advisors and Independent Contractors may only conduct business with the residents of the states and/or jurisdictions for which they are properly registered.
Wedbush is an affiliate of Qapital, a fintech company. Advisory services associated with Wedbush Next Powered by Qapital are provided by Qapital Invest, LLC (“Qapital Invest”) an SEC-registered investment advisor and affiliate of Wedbush. Sales representatives associated with Wedbush Securities Inc. may receive compensation for referrals to Qapital and/or Qapital Invest.
Securities and Investment Advisory services are offered through Wedbush Securities, Inc. Member NYSE/FINRA/SIPC.
Third party entities named are not associated with Wedbush Securities.
Investment professionals may only conduct business and provide recommendations with residents of the states for which they are properly licensed. You can check the registration and background of an investment professional and their firm.
Please refer to FINRA’s BrokerCheck website for this information: FINRA’s BrokerCheck.
Fixed income securities are subject to increased loss of principal during periods of rising interest rates and are subject to various other risks including changes in credit quality, market valuations, liquidity, prepayments, early redemption, corporate events, tax ramifications, and other factors. Investors should consider carefully information contained in the prospectus, including investment objectives, risks, charges, and expenses. You can request a prospectus by contacting your Wedbush Financial Advisor and/or Registered Representative. Past performance is never a guarantee of future returns.
BrokerCheck is a trusted tool that shows you employment history, certifications, licenses, and any violations for brokers and investment advisors.
